ASXL1/EZH2突变促进PMF中肿瘤性造血干细胞的克隆扩增并损害红系生成
该研究对PMF患者CD133+造血干细胞和祖细胞进行超过2000个集落的基因分型,发现染色质调控因子ASXL1和/或EZH2突变是最早的遗传学事件,先于JAK2-V617F和CALR突变,且双突变患者HSC在免疫缺陷小鼠中植入显著更高,EZH2突变与红系祖细胞成熟受损和细胞周期阻滞相关。
要点
- ASXL1和/或EZH2突变是PMF部分患者克隆性髓系生成的驱动事件,先于JAK2-V617F和CALR突变。
- 双ASXL1/EZH2突变PMF患者HSC在免疫缺陷小鼠中植入显著高于无组蛋白修饰突变患者。
- EZH2突变与PMF患者红系生成异常相关,表现为红系祖细胞成熟受损和细胞周期阻滞。
核心结论
- 组蛋白转录后修饰因子在肿瘤性干细胞中具有重要作用,其克隆性生长维持PMF中异常髓系生成和白血病前期克隆的扩增。
研究设计与样本
- 对PMF患者CD133+造血干细胞和祖细胞来源的超过2000个集落进行基因分型。
- 将PMF患者HSC移植入免疫缺陷小鼠以评估植入能力。
主要发现
- 从PMF患者CD133+HSC和祖细胞获取的超过2000个集落基因分型证实肿瘤性群体内存在复杂遗传异质性。
- 染色质调控因子ASXL1和/或EZH2突变被确定为最早的遗传学病变,先于JAK2-V617F和CALR突变。
- 双ASXL1/EZH2突变PMF患者HSC在免疫缺陷小鼠中的植入显著高于无组蛋白修饰突变患者。
- EZH2突变与PMF患者红系生成异常相关,表现为红系祖细胞成熟受损和细胞周期阻滞。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary myelofibrosis (PMF) is a hematopoietic stem cell (HSC) disease, characterized by aberrant differentiation of all myeloid lineages and profound disruption of the bone marrow niche. PMF samples carry several mutations, but their cell origin and hierarchy in regulating the different waves of clonal and aberrant myeloproliferation from the prime HSC compartment is poorly understood. Genotyping of >2000 colonies from CD133+HSC and progenitors from PMF patients confirmed the complex genetic heterogeneity within the neoplastic population. Notably, mutations in chromatin regulators ASXL1 and/or EZH2 were identified as the first genetic lesions, preceding both JAK2-V617F and CALR mutations, and are thus drivers of clonal myelopoiesis in a PMF subset. HSC from PMF patients with double ASXL1/EZH2 mutations exhibited significantly higher engraftment in immunodeficient mice than those from patients without histone modifier mutations. EZH2 mutations correlate with aberrant erythropoiesis in PMF patients, exemplified by impaired maturation and cell cycle arrest of erythroid progenitors. These data underscore the importance of post-transcriptional modifiers of histones in neoplastic stem cells, whose clonal growth sustains aberrant myelopoiesis and expansion of pre-leukemic clones in PMF.
引用
- Triviai I, Zeschke S, Rentel J, et al. ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF. Leukemia. 2018. PMID: 29907810. doi:10.1038/s41375-018-0159-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。